Evidence map›Paper›PMID 41827728›Full record

ReviewCancers2026

The Role of Prognostic Clinical-Pathological, (Immuno-) Histological, and Molecular Parameters in Pseudomyxoma Peritonei Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis.

Jan Philipp Ramspott, Anna Kolmhofer, Lukas Schabl-Cayron, Philipp Schredl, Klaus Emmanuel, Dino Bekric, Jaroslav Presl, Andreas Pascher, Daniel Neureiter, Tarkan Jäger

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jan Philipp RamspottDepartment of General, Visceral and Transplant Surgery, University Hospital Muenster, 48149 Muenster, Germany.ORCID 0000-0001-9248-2294
Anna KolmhoferLaboratory of Immunological and Molecular Cancer Research, Department of Internal Medicine III, Salzburg Cancer Research Institute, 5020 Salzburg, Austria.
Lukas Schabl-CayronDepartment of Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Philipp SchredlDepartment of Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-2007-9636
Klaus EmmanuelDepartment of Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
Dino BekricInstitute of Pathology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0003-3928-519X
Jaroslav PreslDepartment of Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-2899-6706
Andreas PascherDepartment of General, Visceral and Transplant Surgery, University Hospital Muenster, 48149 Muenster, Germany.
Daniel NeureiterInstitute of Pathology, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0001-9155-5762
Tarkan JägerDepartment of Surgery, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-2390-0226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercancer detectioncytoreductive surgeryglobal cancer carehyperthermic intraperitoneal chemotherapyoncological outcomesprognosispseudomyxoma peritoneirisk factor

Identifiers

PMID41827728
PMCPMC12984246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.